Verywell Health on MSN1y
Lung Cancer Liver Metastasis
Medically reviewed by Gagandeep Brar, MD Lung cancer liver metastases are tumors that form in the liver from cancer cells ...
The American Journal of Managed Care18d
Non-Small Cell Lung Cancer
The FDA approved the FoundationOne Liquid CDx to identify patients with metastatic non–small cell lung cancer (mNSCLC) with MET exon 14 skipping alterations who may be eligible for tepotinib ...
Targeted Oncology23h
Tarlatamab’s Impact on Platinum-Sensitive or -Refractory SCLC
Ticiana Leal, MD, discussed the case of a 73-Year-Old woman with progressive extensive-stage small cell lung cancer.
Healio11d
FDA grants priority review to oral non-small cell lung cancer drug
The FDA granted priority review to a new drug application for sunvozertinib as an oral treatment for certain patients with ...
Pharmaceutical Technology19d
Vebreltinib DR by Apollomics for Non-Small Cell Lung Cancer: Likelihood of Approval
Vebreltinib DR is under clinical development by Apollomics and currently in Phase II for Non-Small Cell Lung Cancer.